Article Text
Abstract
This review looks at the nature and impact of communication changes in Parkinson’s disease, approaches to assessment and directions for intervention. This is especially important since medical and surgical interventions that help limb movement are largely ineffective, or even detrimental, for speech. Most people with Parkinson’s disease notice changes to their communication. Voice alters early on—even in the prodromal stage. Later, articulation may impair intelligibility further. These changes impact on mood and social participation. However, a full characterisation of communication changes in Parkinson’s must acknowledge that changes are far more pervasive and varied than a quiet voice. Communication is affected by marked dysprosody, cognitive-linguistic impairment, alterations to social interaction and pragmatics. Changes entail not just expressive elements but also receptive. A comprehensive evaluation of potential communication challenges faced by people with Parkinson’s disease must cover all these aspects. Similarly, interventions that ignore the breadth and depth of changes will always remain incomplete.
- parkinson's speech language assessment management
Statistics from Altmetric.com
Linked Articles
- Editors' commentary
Read the full text or download the PDF:
Other content recommended for you
- Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease
- Prevalence and pattern of perceived intelligibility changes in Parkinson’s disease
- Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation
- Is speech function lateralised in the basal ganglia? Evidence from de novo Parkinson’s disease
- Parkinson’s disease: etiopathogenesis and treatment
- Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease
- One side effect: two networks? Lateral and posteromedial stimulation spreads induce dysarthria in subthalamic deep brain stimulation for Parkinson’s disease
- Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson’s disease: a randomised blinded evaluation
- Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a ‘new form of the disease’
- Deep brain stimulation for movement disorders